JP2024543455A5 - - Google Patents

Info

Publication number
JP2024543455A5
JP2024543455A5 JP2024527767A JP2024527767A JP2024543455A5 JP 2024543455 A5 JP2024543455 A5 JP 2024543455A5 JP 2024527767 A JP2024527767 A JP 2024527767A JP 2024527767 A JP2024527767 A JP 2024527767A JP 2024543455 A5 JP2024543455 A5 JP 2024543455A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
peptide contains
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543455A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079681 external-priority patent/WO2023086913A2/en
Publication of JP2024543455A publication Critical patent/JP2024543455A/ja
Publication of JP2024543455A5 publication Critical patent/JP2024543455A5/ja
Pending legal-status Critical Current

Links

JP2024527767A 2021-11-11 2022-11-11 リラキシン-2融合タンパク質類似体及びそれを使用する方法 Pending JP2024543455A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163263917P 2021-11-11 2021-11-11
US63/263,917 2021-11-11
PCT/US2022/079681 WO2023086913A2 (en) 2021-11-11 2022-11-11 Relaxin-2 fusion protein analogs and methods of using same

Publications (2)

Publication Number Publication Date
JP2024543455A JP2024543455A (ja) 2024-11-21
JP2024543455A5 true JP2024543455A5 (https=) 2025-11-19

Family

ID=86336636

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527767A Pending JP2024543455A (ja) 2021-11-11 2022-11-11 リラキシン-2融合タンパク質類似体及びそれを使用する方法

Country Status (10)

Country Link
US (1) US12509497B2 (https=)
EP (1) EP4429694A4 (https=)
JP (1) JP2024543455A (https=)
KR (1) KR20240110824A (https=)
CN (1) CN118510536A (https=)
AU (1) AU2022388751A1 (https=)
CA (1) CA3237801A1 (https=)
IL (1) IL312731A (https=)
MX (1) MX2024005654A (https=)
WO (1) WO2023086913A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118510536A (zh) 2021-11-11 2024-08-16 泰克托尼治疗股份有限公司 松弛素-2融合蛋白类似物及其使用方法
AU2024270919A1 (en) 2023-05-18 2026-01-15 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835251A (en) 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
WO2007115414A1 (en) 2006-04-11 2007-10-18 University Of Guelph Modified h2 relaxin for tumor suppression
WO2009055854A1 (en) 2007-10-30 2009-05-07 Howard Florey Institute Of Experimental Physiology And Medicine Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides
WO2010105081A1 (en) 2009-03-13 2010-09-16 Medtronic, Inc. Method of treating heart failure
US8389475B2 (en) 2009-08-10 2013-03-05 The Board Of Trustees Of The Leland Stanford Junior University Relaxin analogs
US20110243943A1 (en) 2010-04-02 2011-10-06 Athena Discovery, Inc. Treatment using relaxin-fusion proteins with extended in vivo half-lives
EA030886B1 (ru) 2010-08-17 2018-10-31 Амбркс, Инк. Модифицированные полипептиды релаксина, содержащие некодируемую в природе аминокислоту, связанную с полимером, и их применение
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
EP2614076A4 (en) 2010-09-08 2014-03-05 Florey Howard Inst CHANGED RELAXIN POLYPEPTIDES
GB201110833D0 (en) 2011-06-24 2011-08-10 Bold Venture Llc Compositions
RU2014103288A (ru) 2011-07-01 2015-08-10 Байер Интеллектчуал Проперти Гмбх Слитые полипептиды релаксина и их применение
KR20140039257A (ko) 2011-07-08 2014-04-01 바이엘 인텔렉쳐 프로퍼티 게엠베하 릴랙신을 방출하는 융합 단백질 및 이의 용도
JP6276690B2 (ja) 2011-08-04 2018-02-07 ファリス バイオテック ゲーエムベーハー ヒトリラキシン−2を調製する方法
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
WO2013177529A1 (en) 2012-05-24 2013-11-28 Angion Biomedica Corp. Relaxin-like compounds and uses thereof
WO2014040008A1 (en) 2012-09-10 2014-03-13 Angion Biomedica Corp. Relaxin-like peptides and uses thereof
US9381231B2 (en) 2012-10-09 2016-07-05 University Of Florida Research Foundation, Inc. Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies
US20150232526A1 (en) 2012-10-10 2015-08-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of relaxin to treat atrial fibrillation
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
US9907833B2 (en) 2013-07-25 2018-03-06 University Of Florida Research Foundation, Incorporated Use of relaxin to treat placental syndromes
JP6822839B2 (ja) 2013-09-13 2021-01-27 ザ・スクリップス・リサーチ・インスティテュート 修飾された治療剤、及びその組成物
KR20160055940A (ko) 2013-09-24 2016-05-18 엘라스타겐 피티와이 리미티드 단백질 추출 방법
EP3068891A1 (en) 2013-11-13 2016-09-21 Aequus Biopharma Inc. Engineered glycoproteins and uses thereof
RU2711322C1 (ru) * 2013-12-20 2020-01-16 Ф. Хоффманн-Ля Рош Аг Улучшенные способы получения рекомбинантного полипептида
EP3131925B1 (en) 2014-04-17 2020-02-19 The Florey Institute of Neuroscience and Mental Health Modified relaxin b chain peptides
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
WO2016144968A1 (en) 2015-03-09 2016-09-15 University Of Washington Relaxin therapy for disorders of the diaphragm
GB201516068D0 (en) 2015-09-10 2015-10-28 Biomed Ltd B V Novel therapy
PT3387019T (pt) 2015-12-09 2022-01-14 Scripps Research Inst Proteínas de fusão de imunoglobulina de relaxina e métodos de uso
IL263079B2 (en) 2016-05-18 2024-05-01 Modernatx Inc Polynucleotides encoding relaxin
WO2018023170A1 (en) 2016-08-04 2018-02-08 Hudson Institute of Medical Research A method of treatment
WO2018068047A1 (en) 2016-10-07 2018-04-12 Beth Israel Deaconess Medical Center, Inc. Compositions comprising relaxin and methods of use thereof
EP3574004A1 (en) * 2017-01-25 2019-12-04 Medimmune, LLC Relaxin fusion polypeptides and uses thereof
PE20191716A1 (es) * 2017-02-08 2019-12-05 Bristol Myers Squibb Co Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos
WO2019149781A1 (en) 2018-01-31 2019-08-08 Sanofi Modified lipidated relaxin b chain peptides and their therapeutic use
TW201934572A (zh) 2018-01-31 2019-09-01 法商賽諾菲公司 經修飾之鬆弛素b鏈胜肽及其治療用途
NZ766762A (en) 2018-01-31 2026-03-27 Sanofi Sa Modified lipidated relaxin b chain peptides and their therapeutic use
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
WO2021094626A1 (en) 2019-11-16 2021-05-20 Relaxera Pharmazeutische Gmbh & Co. Kg Medical composition for treating cardiac wasting and cachexia
CN115768801A (zh) * 2020-05-08 2023-03-07 哈佛学院院长等 工程化松弛素及其使用方法
JP2023526512A (ja) 2020-05-22 2023-06-21 トラスティーズ オブ ボストン ユニバーシティ 線維化疾患を処置するための方法および組成物
US20210380655A1 (en) 2020-06-02 2021-12-09 Trustees Of Boston University Production of soluble relaxin and relaxin analogs
CA3186143A1 (en) 2020-06-17 2021-12-23 Medimmune Limited Heterodimeric relaxin fusions and uses thereof
CN114075276A (zh) 2020-08-17 2022-02-22 成都奥达生物科技有限公司 一种长效松弛素2类似物
CN113577289A (zh) 2021-01-11 2021-11-02 张莉 Rxfp1/3抑制剂在制备预防或治疗青少年特发性脊柱侧凸疾病的药物中的用途
AU2022334113A1 (en) 2021-08-23 2024-03-14 River 2 Renal Corp. Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions
CA3230581A1 (en) 2021-09-14 2023-03-23 Bellylabs Oy Assay method for relaxin
WO2023056044A1 (en) 2021-10-01 2023-04-06 Modernatx, Inc. Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
CN118510536A (zh) 2021-11-11 2024-08-16 泰克托尼治疗股份有限公司 松弛素-2融合蛋白类似物及其使用方法
AU2022410335A1 (en) 2021-12-15 2024-07-18 Medimmune Limited Treatment using heterodimeric relaxin fusions
CA3252059A1 (en) 2022-05-07 2025-07-07 Beijing Tuo Jie Biopharmaceutical Co. Ltd. Relaxin fusion protein or analogue and its medical use
JP2025528469A (ja) 2022-08-31 2025-08-28 リラクセラ ファルマツォイティッシュ ゲゼルシャフト エムベーハー ウント コー. カーゲー 免疫抑制薬及び処置方法
AU2024270919A1 (en) * 2023-05-18 2026-01-15 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Similar Documents

Publication Publication Date Title
Wang et al. Therapeutic peptides: current applications and future directions
JP2024543455A5 (https=)
JP2018171063A5 (https=)
JP6545759B2 (ja) アゴニストおよびアンタゴニストとしての循環置換により修飾されるリガンド
CN103140236B (zh) 生长激素多肽及其制备和使用方法
JP2020028308A5 (https=)
RU2018117674A (ru) Композиции и способы для экспрессии нескольких биологически активных полипептидов с одного вектора для лечения заболеваний сердца и других патологий
US20020058619A1 (en) Ligand for vascular endothelial growth factor receptor
WO2008051505A2 (en) Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
JP2014508510A5 (https=)
JP2023524981A5 (https=)
JP2010536356A5 (https=)
JP2024509241A5 (https=)
WO2021083301A1 (zh) 多肽的生产和纯化方法
JP2023548945A5 (https=)
Sohma et al. Comparative properties of insulin-like growth factor 1 (IGF-1) and [Gly7D-Ala] IGF-1 prepared by total chemical synthesis
US12565516B2 (en) Carrier protein for improving properties of bioactive protein
US8008257B2 (en) ANF fusion proteins
JP2023516653A5 (https=)
CA3180251A1 (en) Cytokine conjugates
HUP0303306A2 (hu) Szívbetegségek megelőzésére és kezelésére alkalmazható IL-18 inhibitorok
CN105524147A (zh) 重组聚多肽及其应用
JP2023529892A5 (https=)
CN105085659B (zh) 一种重组利钠肽及其制备方法
JP7544599B2 (ja) ペプチドの血中動態改善方法